Lucid Diagnostics Inc. LUCD 深 沪
已收盘 02-06 16:00:00 美东时间
1.22
+0.070
+6.09%
华盛通- 最 高1.24
- 今 开1.17
- 成交量 104.35万股
- 最 低 1.164
- 昨 收 1.15
- 总市值 1.60亿
- 52周最高 1.80
- 市盈率 静 --
- 换手率 0.80%
- 52周最低 0.9495
- 委 比 -93.51%
- 总股本 1.31亿
- 历史最高 13.52
- 量 比 1.06
- 振 幅 6.61%
- 历史最低 0.6301
- 每 手 1
- 风险率 0.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多What's Going On With PAVmed Shares Thursday?
PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contract
01-22 22:23
Why Is PAVmed Stock Skyrocketing Wednesday?
Pavmed Inc. (PAVM) surges as its subsidiary Lucid Diagnostics (LUCD) secures a contract with VA for its cancer prevention test.
01-22 00:22
PAVmed-subsidiary Lucid Diagnostics spikes on Veterans Affairs contract
Lucid Diagnostics (LUCD), a subsidiary of healthcare equipment maker PAVmed (PAVM), added ~10% in the premarket on Wednesday after the company announced that the U.S. Department of Veterans Affairs ha...
01-21 21:47
Lucid Diagnostics Wins VA Contract For EsoGuard, Expanding Esophageal Cancer Screening Across Nationwide VA Healthcare System
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced that it has been
01-21 21:10
PAVmed Announces Reverse Stock Split
NEW YORK, Dec. 30, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, di...
2025-12-30 22:01
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
2025-12-11 10:33
Lucid Diagnostics Files Prospectus To Raise Up To $175M Through Sale Of Stock, Debt And Warrants
Lucid Diagnostics Inc. $175,000,000 Common Stock, Preferred Stock, Debt Securities, Warrants and Units We may offer and sell from time to time shares of common stock, shares of preferred stock, debt
2025-12-06 06:09
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
2025-11-14 10:43
Needham Reiterates Buy on Lucid Diagnostics, Maintains $3 Price Target
Needham analyst Mike Matson reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $3 price target.
2025-11-13 19:00
Lucid Diagnostics Q3 Adj. EPS $(0.10) Beats $(0.11) Estimate, Sales $1.211M Miss $1.357M Estimate
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 50 percent increase over losses of $(0.20) per share from the
2025-11-12 21:09
